Methods and materials for treating autoimmune and/or complement mediated diseases and conditions
First Claim
Patent Images
1. A method for treating myasthenia gravis in a subject comprising the step of:
- administering to the subject a C2 small interfering RNA (siRNA) that inhibits the classical complement pathway.
1 Assignment
0 Petitions
Accused Products
Abstract
Disclosed are methods for treating an autoimmune and/or complement mediated disease or condition in a subject. The methods include administering to the subject a compound which inhibits the subject'"'"'s classical complement pathway. The methods include administering to the subject a compound which inhibits the subject'"'"'s classical complement pathway. Compositions which include inhibitors of C1q, C1r, C1s, C2 or C4 and a pharmaceutically acceptable excipient are also described.
-
Citations
3 Claims
-
1. A method for treating myasthenia gravis in a subject comprising the step of:
- administering to the subject a C2 small interfering RNA (siRNA) that inhibits the classical complement pathway.
- View Dependent Claims (2, 3)
Specification